These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 7570065)

  • 21. Constitutive activation of JAKs and STATs in BCR-Abl-expressing cell lines and peripheral blood cells derived from leukemic patients.
    Chai SK; Nichols GL; Rothman P
    J Immunol; 1997 Nov; 159(10):4720-8. PubMed ID: 9366395
    [TBL] [Abstract][Full Text] [Related]  

  • 22. e6a2 BCR-ABL transcript in chronic myeloid leukemia: is it associated with aggressive disease?
    Colla S; Sammarelli G; Voltolini S; Crugnola M; Sebastio P; Giuliani N
    Haematologica; 2004 May; 89(5):611-3. PubMed ID: 15136228
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Monitoring of plasma imatinib concentration for the effective treatment of CML patients.
    Tsutsumi Y; Kanamori H; Yamato H; Ehira N; Miura T; Kawamura T; Obara S; Tanaka J; Asaka M; Imamura M; Masauzi N
    Leuk Res; 2004 Oct; 28(10):1117-8. PubMed ID: 15289027
    [No Abstract]   [Full Text] [Related]  

  • 24. Endotoxin, tumor necrosis factor, and related mediators: new approaches to shock.
    Beutler B
    New Horiz; 1993 Feb; 1(1):3-12. PubMed ID: 7922391
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel tyrosine kinase inhibitors in chronic myelogenous leukemia.
    Jabbour E; Cortes J; Kantarjian H
    Curr Opin Oncol; 2006 Nov; 18(6):578-83. PubMed ID: 16988578
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cytokines as a key component of cancer-related inflammation.
    Germano G; Allavena P; Mantovani A
    Cytokine; 2008 Sep; 43(3):374-9. PubMed ID: 18701317
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acute myeloid leukemia developing during imatinib mesylate therapy for chronic myeloid leukemia in the absence of new cytogenetic abnormalities.
    Pawarode A; Sait SN; Nganga A; Coignet LJ; Barcos M; Baer MR
    Leuk Res; 2007 Nov; 31(11):1589-92. PubMed ID: 17391756
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interferon-alpha-treated patients with chronic myelogenous leukemia show BCR/ABL-positive peripheral blood progenitor cells surviving long-term culture.
    Schultheis B; Heissig B; Pasternak G; Hörner S; Hehlmann R
    Folia Biol (Praha); 2000; 46(6):251-5. PubMed ID: 11140858
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fludarabine, cytarabine, G-CSF and idarubicin (FLAG-IDA) for the treatment of relapsed or poor risk childhood acute leukemia.
    Yalman N; Sarper N; Devecioğlu O; Anak S; Eryilmaz E; Can M; Yenilmez H; Ağaoğlu L; Gedikoğlu G
    Turk J Pediatr; 2000; 42(3):198-204. PubMed ID: 11105617
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biology of proinflammatory cytokines and their antagonists.
    Moldawer LL
    Crit Care Med; 1994 Jul; 22(7):S3-7. PubMed ID: 8026189
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biochemically targeted therapy of refractory leukemia and myeloid blast crisis of chronic granulocytic leukemia with Tiazofurin, a selective blocker of inosine 5'-phosphate dehydrogenase activity.
    Tricot G; Weber G
    Anticancer Res; 1996; 16(6A):3341-7. PubMed ID: 9042309
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Involvement of TNF-alpha secreting macrophages in lethal forms of human graft-versus-host disease.
    Facon T; Jouet JP; Noel-Walter MP; Bloget F; Bauters F; Janin A
    Bone Marrow Transplant; 1997 Sep; 20(6):511-5. PubMed ID: 9313887
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of BCR - ABL in M1 myeloid leukemia cells induces differentiation without arresting proliferation.
    Cambier N; Zhang Y; Vairo G; Kosmopoulos K; Metcalf D; Nicola NA; Elefanty AG
    Oncogene; 1999 Jan; 18(2):343-52. PubMed ID: 9927191
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Limitations of Sokal score in patients with chronic myeloid leukemia.
    Hamadani SM; Chaudhary L
    J Coll Physicians Surg Pak; 2007 Mar; 17(3):182; author reply 182. PubMed ID: 17374310
    [No Abstract]   [Full Text] [Related]  

  • 35. Biological properties and growth in SCID mice of a new myelogenous leukemia cell line (KBM-5) derived from chronic myelogenous leukemia cells in the blastic phase.
    Beran M; Pisa P; O'Brien S; Kurzrock R; Siciliano M; Cork A; Andersson BS; Kohli V; Kantarjian H
    Cancer Res; 1993 Aug; 53(15):3603-10. PubMed ID: 8339266
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Actions of cytokines on the immune response and viral interactions: an overview.
    Peters M
    Hepatology; 1996 Apr; 23(4):909-16. PubMed ID: 8666349
    [No Abstract]   [Full Text] [Related]  

  • 37. Gleditsia sinensis fruit extract is a potential chemotherapeutic agent in chronic and acute myelogenous leukemia.
    Chow LM; Chui CH; Tang JC; Teo IT; Lau FY; Cheng GY; Wong RS; Leung TW; Lai KB; Yau MY; Gou D; Chan AS
    Oncol Rep; 2003; 10(5):1601-7. PubMed ID: 12883747
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular analysis of a case of Philadelphia chromosome-positive acute myeloid leukemia.
    Yoshida A; Kishi S; Kita K; Kamada N; Nakamura T; Ueda T
    Anticancer Res; 1997; 17(1B):625-8. PubMed ID: 9066590
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The potential role of therapeutic cytokine manipulation in acute pancreatitis.
    Denham W; Norman J
    Surg Clin North Am; 1999 Aug; 79(4):767-81. PubMed ID: 10470326
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Cytokines and anti-cytokines in chronic inflammatory intestinal diseases].
    Desreumaux P; Meresse B; Cortot A; Colombel JF
    Gastroenterol Clin Biol; 1999 Jun; 23(5 Pt 2):B159-68. PubMed ID: 10897788
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.